Recent Quarter Total Invested
$4.31 M
Recent Quarter Institutional Ownership Percentage
13.12%
Total Invested of Last Quarter
$2.96 M
Ownership Percentage of Last Quarter
11.13%
Enlivex Therapeutics Ltd. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 11/14/2024 | 2.14 M | $3.59 M | 25.78% | 10.94% |
| MORGAN STANLEY | 11/14/2024 | 245,754 | $412,867 | 0.35% | 1.26% |
| RENAISSANCE TECHNOLOGIES LLC | 11/13/2024 | 74,789 | $125,646 | 4.32% | 0.38% |
| SIGMA INVESTMENT COUNSELORS INC | 10/23/2024 | 30,000 | $50,400 | 100.00% | 0.15% |
| XTX TOPCO LTD | 11/14/2024 | 22,659 | $38,067 | -8.71% | 0.12% |
| CITADEL ADVISORS LLC | 11/14/2024 | 20,800 | $34,944 | 29.19% | 0.11% |
| GOLDMAN SACHS GROUP INC | 11/14/2024 | 13,935 | $23,411 | 21.93% | 0.07% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2024 | 10,420 | $17,505 | 0.00% | 0.05% |
| WELLS FARGO & COMPANY/MN | 11/13/2024 | 9,184 | $15,429 | 0.00% | 0.05% |
| GROUP ONE TRADING, L.P. | 11/14/2024 | 5,730 | $9,626 | -0.33% | 0.03% |
| UBS GROUP AG | 11/14/2024 | 3,217 | $5,405 | 20,006.25% | 0.02% |
| CITADEL ADVISORS LLC | 11/14/2024 | 3,000 | $5,040 | -11.76% | 0.02% |
| SIGNATUREFD, LLC | 10/21/2024 | 3,000 | $5,040 | 100.00% | 0.02% |
| STEWARD PARTNERS INVESTMENT ADVISORY, LLC | 11/14/2024 | 3,000 | $5,040 | 0.00% | 0.02% |
| JPMORGAN CHASE & CO | 11/08/2024 | 1,814 | $3,048 | 685.28% | 0.01% |
| ACTIVEST WEALTH MANAGEMENT | 11/12/2024 | 1,000 | $1,680 | 0.00% | 0.01% |
| SRS CAPITAL ADVISORS, INC. | 11/06/2024 | 615 | $1,034 | 0.00% | 0.00% |
| ADVISOR GROUP HOLDINGS, INC. | 11/13/2024 | 400 | $672 | 0.00% | 0.00% |
| RED TORTOISE LLC | 10/28/2024 | 150 | $252 | 0.00% | 0.00% |
| BANK OF AMERICA CORP /DE/ | 11/14/2024 | 145 | $244 | 100.00% | 0.00% |
| GLOBAL RETIREMENT PARTNERS, LLC | 10/16/2024 | 11 | $18 | 0.00% | 0.00% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 11/14/2024 | 0 | $0 | -100.00% | 0.00% |
Enlivex Therapeutics Ltd.institutional Ownership - Frequently Asked Questions
-
Who are the largest shareholders of ENLV shares?
During the previous two years, 23 institutional investors and hedge funds held shares of Enlivex Therapeutics Ltd.. The most heavily invested institutionals were:
ARMISTICE CAPITAL, LLC: 2.14 M
MORGAN STANLEY: 245,754
RENAISSANCE TECHNOLOGIES LLC: 74,789
SIGMA INVESTMENT COUNSELORS INC: 30,000
XTX Topco Ltd: 22,659
GOLDMAN SACHS GROUP INC: 13,935
-
What percentage of Enlivex Therapeutics Ltd. stock is owned by institutional investors?
13.12% of Enlivex Therapeutics Ltd. stock is owned by institutional investors.
-
How much institutional buying is happening at ENLV ?
Institutional investors have bought a total of 2.58 M shares in the last 24 months. This purchase volume represents approximately $2.35 M in transactions.